about
On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosisProgrammed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usageMetagenomic detection of phage-encoded platelet-binding factors in the human oral cavity.Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapyFluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.Epstein-Barr virus and skin manifestations in childhood.Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression.Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphismsA novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association.A novel tetrameric gp350 1-470 as a potential Epstein-Barr virus vaccine.Self-assembly of Epstein-Barr virus capsids.The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosisComparative pathobiology of macaque lymphocryptoviruses.The expression of renal Epstein-Barr virus markers in patients with lupus nephritis.Thymoquinone efficiently inhibits the survival of EBV-infected B cells and alters EBV gene expression.Effect of high dose vitamin C on Epstein-Barr viral infection.The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral productionEvaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.Erythema multiforme-like lesions in the course of infectious mononucleosis.Atypical infectious mononucleosis in a patient receiving tumor necrosis factor alpha inhibitory treatment.Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay.Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus.Sudden death and Angelman syndrome.Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins.The Role of the Polymeric Immunoglobulin Receptor and Secretory Immunoglobulins during Mucosal Infection and Immunity.Failure to detect an association between aggressive periodontitis and the prevalence of herpesviruses.
P2860
Q24645207-13678BBE-A656-41A1-9404-A35BD80765B8Q28749172-F954D487-39FF-45EA-85E8-171D0BD36314Q30499059-EFF17AC3-1ECA-4262-BB7A-40D3EA47489DQ30878158-EFD96490-8971-48C8-889E-43337773B03AQ33634792-76113947-DA7C-4A98-BF5F-2E0EC47952F1Q34373828-5A38EA0F-4574-4AD4-84EC-E2A9F3FC0D3FQ35476446-5D1D33DA-6F2B-4829-A543-2A8ADA311B5EQ35807158-D575623B-D118-4B6F-8CD5-A81A755B2534Q36318425-856BB9E4-AFAB-4492-878F-65230CD2B19DQ36979271-E43BE4AD-59AF-4FE2-B673-2B3BAB4DCC1FQ37145249-AC466EC7-DA86-450A-AE32-187B666CEC95Q37151141-204775DB-7A63-4FF0-9A08-A850D772E038Q37243867-8A27353A-DC4E-4E47-8B16-743CB748AE72Q37710075-FFD987B9-E245-48C4-A3C6-329E4A79D672Q39254946-C809872B-F129-468A-B59C-1061BAEB3781Q39427990-006AF370-921A-469E-A457-115EE6BE42B2Q39735571-2E07AB2A-F83A-458E-BFE3-7CB6FEC43B26Q40141454-0CE06124-DA54-47F9-AA0C-BC35098D0DFBQ40373163-617B4F53-B9C5-4B51-92B6-33FA74134D71Q40403965-C901170C-5829-46EA-95B4-20640101AB86Q40683052-AB369EE3-4461-416F-B241-B2A749F224ADQ42207455-B2D79772-60CD-4F52-B664-4F5990B4EA8AQ42261208-EAA9052E-5FC5-476D-8F08-324F4CB2ED2CQ43589817-D1D345DF-F835-498E-9CA3-FAD8941CE3D9Q44549769-7B1C2150-C874-4B2E-A054-9E33981888CDQ45242764-F72BEB4D-A8D4-4B5A-8B32-5297B0AC1368Q45363582-3697A09E-45AC-4187-85D8-95545C9328D9Q54214321-2E76B80D-FFB0-4CDA-8535-BAFB49CC2365Q54283104-30760B39-2B79-4B2A-BA90-53D93CAB8DBE
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Infectious mononucleosis and Epstein-Barr virus.
@ast
Infectious mononucleosis and Epstein-Barr virus.
@en
Infectious mononucleosis and Epstein-Barr virus.
@nl
type
label
Infectious mononucleosis and Epstein-Barr virus.
@ast
Infectious mononucleosis and Epstein-Barr virus.
@en
Infectious mononucleosis and Epstein-Barr virus.
@nl
prefLabel
Infectious mononucleosis and Epstein-Barr virus.
@ast
Infectious mononucleosis and Epstein-Barr virus.
@en
Infectious mononucleosis and Epstein-Barr virus.
@nl
P1476
Infectious mononucleosis and Epstein-Barr virus.
@en
P2093
Eleni-Kyriaki Vetsika
Margaret Callan
P356
10.1017/S1462399404008440
P577
2004-11-05T00:00:00Z